Medicus Sciences Acquisition Corp. (the "Company") is a newly organized blank check company incorporated in the Cayman Islands on November 26, 2020. The Company was formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with 1 or more businesses ("Business Combination"). The Company is not limited to a particular industry or sector for purposes of consummating a Business Combination. The Company is an early stage and emerging growth company and, as such, the Company is subject to all of the risks associated with early stage and emerging growth companies.
Company profile
Ticker
MSAC, MSACW
Exchange
Employees
Incorporated
Location
Fiscal year end
Industry (SIC)
SEC CIK
MSAC stock data
Latest filings (excl ownership)
15-12G
Securities registration termination
27 Feb 23
25-NSE
Exchange delisting
17 Feb 23
8-K
Medicus Sciences Acquisition Corp. Announces Liquidation
13 Feb 23
8-K
Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard
18 Jan 23
10-Q
2022 Q3
Quarterly report
14 Nov 22
10-Q
2022 Q2
Quarterly report
11 Aug 22
10-Q
2022 Q1
Quarterly report
12 May 22
10-K
2021 FY
Annual report
30 Mar 22
8-K
Departure of Directors or Certain Officers
28 Mar 22
8-K
Regulation FD Disclosure
15 Feb 22
Latest ownership filings
SC 13G/A
First Trust Capital Management L.P.
12 Feb 24
SC 13G/A
Saba Capital Management, L.P.
8 Feb 24
SC 13G
GLAZER CAPITAL, LLC
14 Feb 23
SC 13G
First Trust Capital Management L.P.
14 Feb 23
SC 13G/A
D. E. SHAW & CO, L.P.
14 Feb 23
SC 13G/A
Third Point LLC
10 Feb 23
SC 13G/A
Cowen Financial Products LLC
24 Jan 23
SC 13G
Cowen Financial Products LLC
11 Mar 22
SC 13G
Third Point LLC
14 Feb 22
SC 13G/A
HealthCor Management, L.P.
14 Feb 22
Financial summary
Quarter (USD) | Sep 22 | Jun 22 | Mar 22 | Dec 21 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 21 | Dec 20 | |
---|---|---|---|
Revenue | |||
Cost of revenue | |||
Operating income | |||
Operating margin | |||
Net income | |||
Net profit margin | |||
Cash on hand | |||
Change in cash | |||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 976.56 k | 976.56 k | 976.56 k | 976.56 k | 976.56 k | 976.56 k |
Cash burn (monthly) | 29.59 k | 50.70 k | 58.04 k | 58.56 k | 83.69 k | 161.66 k |
Cash used (since last report) | 556.35 k | 953.43 k | 1.09 mm | 1.10 mm | 1.57 mm | 3.04 mm |
Cash remaining | 420.20 k | 23.13 k | -114.90 k | -124.71 k | -597.24 k | -2.06 mm |
Runway (months of cash) | 14.2 | 0.5 | -2.0 | -2.1 | -7.1 | -12.8 |
Institutional ownership, Q1 2023
29.9% owned by funds/institutions
13F holders | Current |
---|---|
Total holders | 2 |
Opened positions | 0 |
Closed positions | 51 |
Increased positions | 0 |
Reduced positions | 0 |
13F shares | Current |
---|---|
Total value | 0.00 |
Total shares | 2.78 mm |
Total puts | 0.00 |
Total calls | 0.00 |
Total put/call ratio | – |
Largest owners | Shares | Value |
---|---|---|
Medicus Sciences | 2.32 mm | $0.00 |
D. E. Shaw & Co | 459.50 k | $0.00 |